Fundraising FoxUncommon Bio
6 known investors
Find your way into Uncommon Bio
Sign up to see every warm intro you have to Uncommon Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Uncommon Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Uncommon Bio has sold its cultivated meat platform to Vow and is now focusing on SymphoRNA, leveraging its nucleic acid delivery technology.
Founders & leadership
Investors · 6
How we know: Angel Academe's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Global Brain's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Uncommon Bio do?
- Uncommon Bio has sold its cultivated meat platform to Vow and is now focusing on SymphoRNA, leveraging its nucleic acid delivery technology.
- Who are Uncommon Bio's investors?
- Uncommon Bio's investors include Angel Academe, Balderton Capital, Global Brain, ITERATIVE, Lowercarbon Capital, redalpine.